HR Healthcare Realty Trust Inc
Real Estate Investment Trusts · NYSE · SEC CIK 1360604 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $286.64M | $281.85M | $278.99M | $286.30M | $297.76M | $297.50M | $298.98M | $309.77M |
| SG&A expense | $12.44M | $14.36M | $17.34M | $13.79M | $21.77M | $23.48M | $13.53M | $34.21M |
| Interest expense | $44.85M | $45.15M | $43.89M | $48.19M | $52.64M | $53.35M | $54.81M | $58.27M |
| Net income | -$15.76M | -$43.51M | -$56,000 | $14.39M | -$57.74M | -$157.85M | -$44.87M | -$106.85M |
| EPS (basic) | -0.05 | -0.13 | 0.00 | — | -0.17 | -0.45 | -0.13 | — |
| EPS (diluted) | -0.05 | -0.13 | 0.00 | — | -0.17 | -0.45 | -0.13 | — |
| Dividends declared per share | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.31 | 0.31 | 0.31 |
| Weighted avg. shares (diluted) | 340.62M | 342.30M | 347.44M | — | 349.96M | 349.63M | 349.54M | — |
| Banking | ||||||||
| Loans, net | $6.02M | $6.00M | $122.35M | $123.25M | $123.35M | $124.13M | $123.81M | $123.67M |
| Balance sheet | ||||||||
| Cash & equivalents | $17.50M | $18.99M | $26.23M | $26.17M | $43.34M | $25.51M | $25.72M | $68.92M |
| Goodwill | — | — | — | — | — | — | — | $0 |
| Total assets | $8.96B | $9.00B | $9.15B | $9.21B | $9.86B | $10.24B | $10.50B | $10.65B |
| Long-term debt | $4.25B | $4.17B | $4.10B | $3.91B | $4.49B | $4.69B | $4.73B | $4.66B |
| Total debt | $4.25B | $4.17B | $4.10B | $3.91B | $4.49B | $4.69B | $4.73B | $4.66B |
| Total liabilities | $4.83B | $4.73B | $4.65B | $4.53B | $5.11B | $5.35B | $5.35B | $5.35B |
| Shareholders' equity | $4.08B | $4.22B | $4.44B | $4.62B | $4.68B | $4.82B | $5.08B | $5.23B |
| Net debt | $4.23B | $4.15B | $4.08B | $3.89B | $4.44B | $4.67B | $4.71B | $4.59B |
| Shares outstanding | 340.00M | 342.72M | 346.53M | 351.60M | 351.60M | 351.57M | 351.00M | 350.53M |
| Cash flow statement | ||||||||
| Operating cash flow | $122.29M | $142.19M | $52.88M | $132.34M | $113.75M | $163.22M | $47.79M | $138.01M |
| Investing cash flow | -$61.41M | -$7.02M | -$45.31M | $526.48M | $226.28M | -$3.10M | -$38.83M | $418.77M |
| Financing cash flow | -$62.36M | -$142.41M | -$7.50M | -$676.15M | -$322.19M | -$160.18M | -$52.15M | -$514.03M |
| Depreciation & amortization | $128.10M | $128.06M | $128.99M | $127.41M | $143.64M | $153.48M | $150.97M | $160.33M |
| Stock-based compensation | $4.56M | $4.42M | $5.42M | $3.35M | $7.23M | $8.77M | $3.03M | $16.97M |
| Dividends paid | $82.25M | $82.25M | $83.90M | $84.39M | $84.77M | $108.95M | $108.81M | $109.79M |
| Share buybacks | $43,000 | $731,000 | $2.04M | $379,000 | $2.92M | $498,000 | $215,000 | $8.56M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.